13.04.2018 Valneva to Present on Lyme and Zika at the 18thWorld Vaccine Congress in Washington, D.C.more
23.03.2018 Alzheimer´s disease: patients exhibit changes in certain bloos lipids that are typical of premature ageingmore
16.03.2018 Arsanis Granted Key Patents for ASN100 Covering Cross-Neutralizing S. aureus Toxin Antibodiesmore
16.03.2018 Valneva Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunyamore
16.03.2018 Arsanis Reports Financial Results and Highlights for Fourth Quarter and Full Year 2017more